new york (GenomeWeb) – Germany-based BioNTech Diagnostics and Shuwen Biotech, its accomplice in China, announced that their MammaTyper true-time PCR breast cancer stratification equipment has been granted an expedited assessment for regulatory approval through the China meals and Drug Administration (CFDA).
The company will review the diagnostic under a unique process designed to expedite the approval of imaginative items, the companies observed.
0 komentar:
Posting Komentar